US Patent Issued to The University of British Columbia, ProMIS Neurosciences on April 29 for "Humanized antibodies binding to amyloid-beta (A-beta)" (Canadian, American Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,469, issued on April 29, was assigned to The University of British Columbia and ProMIS Neurosciences Inc..

"Humanized antibodies binding to amyloid-beta (A-beta)" was invented by Neil R. Cashman (Vancouver, Canada), Steven S. Plotkin (Vancouver, Canada), Johanne Kaplan (Sherborn, Mass.), Judith Maxwell Silverman (Whistler, Canada) and Ebrima Gibbs (Port Moody, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure pertains to antibodies that bind A-beta oligomers and methods of making and using said antibodies. Also provided are chimeric or humanized antibodies, including antibodies having CDRs in Table 2 and/or having a sequence as set...